Microplasmin: all 22 studies that test it

Page 1 of 1. Open to participants first (0), then studies with results posted, then the rest; newest registration first within each.

• A Study to Evaluate the Efficacy and Safety of Ocriplasmin in Inducing Total PVD in Subjects With NPDRTerminatedNCT02681809Phase 2Results posted
• Ocriplasmin for Vitreomacular Traction/Symptomatic Vitreomacular AdhesionCompletedNCT02322229Phase 4Results posted
• Assessment of Patients Treated With JETREA® for Vitreomacular TractionCompletedNCT02035748Phase 4Results posted
• A Phase III Study of A01016 in Subjects With Symptomatic Vitreomacular AdhesionCompletedNCT01889251Phase 3Results posted
• Ocriplasmin for Treatment for Symptomatic Vitreomacular Adhesion Including Macular HoleCompletedNCT01429441Phase 3Results posted
• Microplasmin Intravitreal Administration in Participants With Uveitic Macular EdemaTerminatedNCT01194674Phase 1/2Results posted
• The Purpose of This Study is to Evaluate the Pharmacokinetic Properties of Intravitreal Ocriplasmin Prior to Planned Primary Pars Plana Vitrectomy (PPV)CompletedNCT01159665Phase 2Results posted
• Clinical Trial of Intravitreal Microplasmin in Infants and Children Scheduled for VitrectomyCompletedNCT00986362Phase 2Results posted
• Safety and Efficacy Study of Intravitreal Ocriplasmin in Subjects With AMD With Focal Vitreomacular AdhesionCompletedNCT00913744Phase 2Results posted
• Trial of Microplasmin Intravitreal Injection for Non-Surgical Treatment of Focal Vitreomacular Adhesion. The MIVI-TRUST (TG-MV-007) Trial.CompletedNCT00798317Phase 3Results posted
• Trial of Microplasmin Intravitreal Injection for Non-surgical Treatment of Focal Vitreomacular Adhesion. The MIVI-TRUST (TG-MV-006) Trial.CompletedNCT00781859Phase 3Results posted
• A Study to Compare Multiple Doses Intravitreal Microplasmin for Treatment of Patients With Vitreomacular Traction (MIVI-IIt)CompletedNCT00435539Phase 2Results posted
• A Study of the Safety and Efficacy of Microplasmin to Induce a Posterior Vitreous Detachment (MIVI III)CompletedNCT00412958Phase 2Results posted
• A Multicenter Study to Compare Multiple Doses of Intravitreal Microplasmin Versus Sham Injection for Treatment of Patients With Diabetic Macular Edema (DME)CompletedNCT00412451Phase 2Results posted
• Phase I RVC With Ocriplasmin for CRVOCompletedNCT02747030Phase 1
• Safety and Efficacy Study of Microplasmin in for Non-Surgical Treatment of Focal Vitreomacular AdhesionCompletedNCT01055535Phase 2
• Study of Intravitreal Microplasmin in Relieving Vitreo-Macular Adhesion in Neovascular Age-related Macular DegenerationStatus unknownNCT00996684Phase 2
• Microplasmin Administered Via the Trellis-8 Infusion System for Treatment of Acute Iliofemoral DVTTerminatedNCT00428129Phase 2
• Intravenous Administration of Microplasmin for Treatment of Acute Ischemic StrokeCompletedNCT00123305Phase 2
• Intra-arterial Microplasmin Administration in Patients With Acute Peripheral Arterial OcclusionTerminatedNCT00123292Phase 2
• Intravitreal Microplasmin in Patients Undergoing Surgical VitrectomyCompletedNCT00123279Phase 2
• Intra-arterial Microplasmin Administration in Patients With Acute Intracranial Vertebrobasilar Artery OcclusionTerminatedNCT00123266Phase 2

← Microplasmin overview